All Publications | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 3 results.

- Journal article
Results of a phase II trial with second-line cystemustine at 60 mg/m(2) in advanced soft tissue sarcoma: A trial of the EORTC early clinical studies group
Cure, H Krakowski, I Adenis, Antoine Tubiana, N Kerbrat, P Roche, H. Chevallier, B Lentz, MA. Fumoleau, P Chollet, P. (1998) European Journal of Cancer — Vol. 34, no. 3, p. 422-423 (1998)
- Journal article
Results of a phase II trial with cystemustine in advanced malignant melanoma. A trial of the EORTC clinical screening group
Urosevic, V Chollet, P. Adenis, Antoine Chauvergne, J. Fargeot, P Roche, H. Kerbrat, P Lentz, MA. Fumoleau, P Chevallier, B (1996) European Journal of Cancer — Vol. 32A, no. 1, p. 181-182 (1996)
- Journal article
Cancer drug development in Europe: A selection of new agents under development at the European Drug Development Network
Lacombe, Denis[UCL] Butler-Smith, A Therasse, Patrick Fumoleau, P Burtles, S Calvert, H Marsoni, S Sessa, C. Verweij, J. (2003) Cancer Investigation — Vol. 21, no. 1, p. 137-147 (2003)